The EFPIA’s Nathalie Moll gives an insight into the work underway across the European pharmaceutical industry to battle COVID-19 in terms of supporting organisations on the ground, ensuring the supply of medicines, and working on the research and development of treatments, vaccines, and diagnostics. Moll also outlines the vital importance of inter-stakeholder collaboration to drive positive outcomes during the pandemic and raises the possibility of a more inter-connected and collaborative industry emerging out of the crisis.
Medical innovation, through the development of treatments and ultimately a vaccine, is the only way out from under the shadow of the coronavirus
